Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction

Frontiers in Physiology

Harry Karmouty-Quintana¹  Mark L. Ormiston⁴  Grazyna Kwapiszewska⁷  Christophe Guignabert⁸ 

[1] Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Houston, TX, United States;Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada;Department of Medicine, Queen's University, Kingston, ON, Canada;Department of Surgery, Queen's University, Kingston, ON, Canada;Institut National de la Santé et de la Recherche Médicale UMR_S 999, Le Plessis-Robinson, France;Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria;Otto Loewi Research Center, Division of Physiology, Medical University of Graz, Graz, Austria;Université Paris-Sud and Université Paris-Saclay, Le Kremlin-Bicêtre, France;

关键词: pulmonary hypertension (PH);    pulmonary hypertension (PH) due to lung diseases and/or hypoxemia;    endothelial cell (EC);    right ventricle (RV) function;    vascular smooth muscle;   

DOI  :  10.3389/fphys.2018.01777

来源: DOAJ

【 授权许可】

Unknown